PROSTATAKREBS-BIOMARKER

European patent · EP3084444 · In force

Register entry

Publication number
EP3084444
Application number
EP14843200
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 19, 2014
Published
Oct 26, 2016
Granted
Jul 17, 2019
Protection ends at the latest
Dec 18, 2034
Next annual fee due
Dec 31, 2026
IPC classes
G01N 33/574 (2006.01)
Priority
GB 201322800 20.12.2013
PCT application
PCT/EP2014/078914 19.12.2014
PCT publication
WO2015/092046 25.06.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Sep 21, 2019

    Agent entered

    Representative
    Kirker & Cie S.A., 122, rue de Genève, Case postale 90, 1226 Geneve-Thônex

    Published in Swissreg on 21.09.2019

  6. Jul 17, 2019

    Granted

    Published in Swissreg on 17.07.2019

Parties

Holder

University College Dublin, National University of Ireland, Dublin

University College Dublin National University Of Ireland, Dublin

Belfield, Dublin 4, IE

Agent

Kirker & Cie SA

Kirker & Cie S.A.

122, rue de Genève Case postale 90, 1226 Geneve-Thônex

Inventor

WATSON, William

Co Dublin, IE

PENNINGTON, Stephen

Co Clare, IE

MURPHY, Brendan

Co Kildare, IE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.